Home › Funds › Integral Health Asset Management, LLC › BBIO

Integral Health Asset Management, LLC position in BBIO

BRIDGEBIO PHARMA INC · Health Care

Integral Health Asset Management, LLC reported holding 300,000 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q3 2026 13F filing — a position valued at US$19.7M, representing 1.28% of its reported portfolio and ranking #20 among its reported holdings. Integral Health Asset Management, LLC has disclosed BBIO holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)300.00K sh
Reported value held$19.74M
Portfolio Weight1.28%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's BBIO position evolved

Integral Health Asset Management, LLC first disclosed a stake in BBIO in Q3 2023 at 275,000 shares (US$7.3M). The position peaked in Q2 2026 at 275,000 shares, worth US$20.5M. Across 5 filings, Integral Health Asset Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 300,000 shares valued at US$19.7M — an increase of 25,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 275.00K $7.25M New
Q1 2025 100.00K $3.46M New
Q1 2026 275.00K $20.42M New
Q2 2026 275.00K $20.48M Hold
Q3 2026 300.00K $19.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 42 other funds we track also report a position in BBIO — the largest reported positions include Jupiter Topco LLC (US$1.05B), Janus Henderson Group (US$978.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$937.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has Integral Health Asset Management, LLC held BBIO?

Integral Health Asset Management, LLC has disclosed BBIO holdings in 5 of the last 13 reported quarters, going back to Q3 2023.

What is Integral Health Asset Management, LLC's current position in BBIO?

As of Q3 2026, Integral Health Asset Management, LLC holds 300.00K shares of BBIO (BRIDGEBIO PHARMA INC), valued at $19.74M, representing 1.28% of its reported portfolio and ranking #20.

Has Integral Health Asset Management, LLC been buying or selling BBIO?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC increased its position in BBIO. The position peaked in Q2 2026 at 275.00K shares.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, Janus Henderson Group, FARALLON CAPITAL MANAGEMENT, L.L.C., among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.